Development of a new system for detection of antibodies against SARS-CoV-2 by researchers from the CBGP

by Centro de Biotecnología y Genómica de Plantas CBGP

4 years ago
SARS-CoV-2, COVID-19, antibodies

SARS-CoV-2 virus is tha infectious agent causing the COVID-19 pandemic, which has swept across the whole world during these last two years, rendering more than 195 millions of infected people and more...

Vall d’Hebron begins the clinical trial in pregnant women of the Pfizer and BioNTech vaccine against COVID-19

by Vall d’Hebron

4 years ago
immunogenicity, vaccine, antibodies, pregnant women, fetus, Covid, Pfizer-BioNTech

The study will evaluate the safety, immunogenicity and efficacy of the vaccine in pregnant women, the passive transfer of antibodies to the fetus and the protection conferred during lactation.

Interferon, the key to many of the worst cases of COVID-19 in young people

by Hospital Universitari de Bellvitge

4 years ago
Interferon, young people, covid-19, pneumonia, cytokine, antibodies, genomics

The international consortium Covid Human Genetic Effort has discovered mutations in eight genes involved in the interferon signalling pathway, the first element in the antiviral response, in young ...

Eurofins Ingenasa is taking part in SaPher project

by Ingenasa

5 years ago
Food allergies, Eurofins Ingenasa, antibodies, SaPher project, allergen industries

Eurofins Ingenasa is taking part in SaPher project, aiming to develop the antibodies of interest not commercially available in the market for the target allergen industries.